Verastem, Inc. 4.5 Million-Share IPO Seen Pricing at $9-$11 a Piece

Cancer drug developer Verastem Inc. expects its initial public offering of 4.5 million shares to price between $9 and $11 apiece.

MORE ON THIS TOPIC